Latest Us Tariffs News

Page 1 of 15
Ansell has entered FY27 with stronger margins, cash generation and shareholder distributions after adjusted EBIT rose 14.9% organically in FY26. The PPE maker is maintaining adjusted EPS guidance of 158 to 170 US cents while targeting further growth from US markets, productivity and a simpler product range.
Victor Sage
Victor Sage
9 Nov 2026
AoFrio’s nine-month revenue fell 20% to NZ$50.3 million as motor sales plunged, while EBITDA dropped to NZ$0.8 million. The NZX-listed refrigeration technology company is relying on new US bottler orders, Food Retail expansion and its IoT platform to support a more profitable 2027.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Orora says strong Cans growth is no longer enough to offset weaker Saverglass earnings, with Group EBIT expected to decline in FY27. The company is targeting more than €30 million in Glass EBIT improvement by FY30 after a €449.7 million non-cash impairment.
Victor Sage
Victor Sage
14 Oct 2026
Bubs Australia delivered 9.2% revenue growth and a sharp underlying EBITDA improvement in FY26, but statutory losses, weaker margins and negative operating cash flow expose the cost of its expansion. Permanent US FDA authorisation removes a major regulatory hurdle, while the annual report still flags material uncertainty around ongoing funding and cash generation.
Victor Sage
Victor Sage
14 Oct 2026
Medical Developments International returned to EBIT profitability in FY26 as Penthrox volumes strengthened across Australian hospitals and Europe. The company now faces the less glamorous test of converting regulatory progress into repeatable demand while absorbing weaker Respiratory sales and new amortisation costs.
Ada Torres
Ada Torres
9 Oct 2026
City Chic Collective lifted FY26 underlying EBITDA 92% to $12.3 million despite a 3.1% revenue decline, helped by stronger ANZ trading, higher margins and a leaner cost base. The retailer remains loss-making after tax, but enters FY27 with $5.2 million in net cash and early signs of renewed store momentum.
Victor Sage
Victor Sage
9 Oct 2026
Delegat Group delivered record operating earnings and cash flow in FY26, but reported profit fell after a NZ$8.7 million impairment and other fair-value adjustments. The NZX-listed wine company is forecasting higher case sales and operating NPAT of NZ$62 million to NZ$66 million for FY27.
Victor Sage
Victor Sage
28 Sept 2026
Waterco Limited (ASX:WAT) delivered record FY26 EBIT of $23.8 million and lifted net profit after tax 59.6% to $15.4 million, despite only modest revenue growth. The stronger result supports a higher fully franked dividend, but the group is carrying more debt and inventory as it expands manufacturing capacity.
Victor Sage
Victor Sage
21 Sept 2026
Delegat Group (NZX:DGL) reported a 20% jump in operating NPAT to NZD 61.5 million for FY26, driven by record EBITDA and a 4% rise in global case sales. The Board declared a 22-cent dividend, up 10%, while net debt fell by NZD 51.8 million.
Victor Sage
Victor Sage
28 Aug 2026
City Chic Collective’s FY26 underlying EBITDA surged 92% to $12.3 million, driven by ANZ growth and cost discipline, while group revenue fell 3.1%. The company enters FY27 with a stronger margin profile and a clean inventory position amid ongoing US tariff challenges.
Logan Eniac
Logan Eniac
24 Aug 2026
Ansell Limited (ASX:ANN) reported a robust FY26 with net profit doubling to US$208.6 million, driven by strong sales growth and operational resilience amid geopolitical challenges. The company also announced a leadership change and reaffirmed its sustainability ambitions.
Victor Sage
Victor Sage
24 Aug 2026
Fisher & Paykel Healthcare has raised its full-year net profit guidance for FY2027, buoyed by robust first-half sales and a $23 million US tariff refund. The medical devices maker forecasts up to 24% profit growth in H1, driven by hospital product demand and operational efficiencies.
Ada Torres
Ada Torres
21 Aug 2026

Browse the archive

Full archive